---
title: "ATOM's price is currently at $1.56, with a potential drop to $1.50 in the next 72 hours, as bears maintain control."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292398699.md"
description: "Currently, ATOM is positioned under all significant moving averages, trading at $1.56. Momentum appears stagnant, and the market is predominantly filled with sell orders. There is a high likelihood of a reevaluation of the $1.50 support level within the next 72 hours, with a 65% probability of this occurring."
datetime: "2026-07-12T09:25:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292398699.md)
  - [en](https://longbridge.com/en/news/292398699.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292398699.md)
generator: "portal-rs"
---

# ATOM's price is currently at $1.56, with a potential drop to $1.50 in the next 72 hours, as bears maintain control.

Currently, ATOM is positioned under all significant moving averages, trading at $1.56. Momentum appears stagnant, and the market is predominantly filled with sell orders. There is a high likelihood of a reevaluation of the $1.50 support level within the next 72 hours, with a 65% probability of this occurring.

### Related Stocks

- [ATOM.US](https://longbridge.com/en/quote/ATOM.US.md)

## Related News & Research

- [Atomera CTO Robert J. Mears disposes of $51,625 in common shares](https://longbridge.com/en/news/297952492.md)
- [Defender Capital LLC. Buys Shares of 295,450 Atomera Incorporated $ATOM](https://longbridge.com/en/news/295503284.md)
- [Chime Financial (CHYM) Could Be 6% Undervalued After Stride Deal And Outlook Lift](https://longbridge.com/en/news/298483669.md)
- [Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market | COSM Stock News](https://longbridge.com/en/news/298467257.md)
- [Atomera Breakthrough Targets Broader RF Adoption of GaN-on-Silicon | ATOM Stock News](https://longbridge.com/en/news/288766229.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**